Clinical outcome score predicts the need for neurodevelopmental intervention after infant heart surgery

J Thorac Cardiovasc Surg. 2013 May;145(5):1248-1254.e2. doi: 10.1016/j.jtcvs.2012.04.029. Epub 2012 Sep 7.

Abstract

Objective: Our goal was to determine if a clinical outcome score derived from early postoperative events is associated with 18- to 24-month Psychomotor Developmental Index (PDI) score among infants undergoing cardiopulmonary bypass surgery.

Methods: We included infants aged ≤6 weeks who underwent surgery during 2002-2006, all of whom were referred for neurodevelopmental evaluation at age 18 to 24 months. We excluded children with chromosomal abnormalities, hearing loss, cerebral palsy, or a Bayley III assessment. The prespecified clinical outcome score had a range of 0 to 7. Lower scores indicated a more rapid postoperative recovery. Patients requiring extracorporeal membrane oxygenation were assigned a score of 7.

Results: Ninety-nine subjects were included. Surgical procedures were arterial switch (n = 36), Norwood (n = 26), repair of total anomalous pulmonary venous connection (n = 16), and other (n = 21). Four subjects had postoperative extracorporeal membrane oxygenation. Clinical outcome scores were highest in the Norwood group (mean 4.1 ± 1.4) compared with the arterial switch group (1.9 ± 1.6) (P < .001), total anomalous pulmonary venous connection group (1.6 ± 2.0) (P < .001), and other group (3.3 ± 1.6, P = not significant). A mean decrease in PDI of 10.9 points (95% confidence interval, 4.9-16.9; P = .0005) was observed among children who had a clinical outcome score ≥3, compared with those with a clinical outcome score <3. Time until lactate ≤2.0 mmol/L increased with increasing clinical outcome score (P = .0003), as did highest 24-hour inotrope score (P < .0001).

Conclusions: Clinical outcome scores of ≥3 were associated with a significantly lower PDI at age 18 to 24 months. This score may be valuable as an end point when evaluating novel potential therapies for this high-risk population.

Publication types

  • Comparative Study

MeSH terms

  • Biomarkers / blood
  • Cardiac Surgical Procedures / adverse effects*
  • Cardiopulmonary Bypass / adverse effects*
  • Cardiotonic Agents / therapeutic use
  • Chi-Square Distribution
  • Child Development*
  • Child, Preschool
  • Developmental Disabilities / diagnosis
  • Developmental Disabilities / etiology*
  • Developmental Disabilities / physiopathology
  • Developmental Disabilities / psychology
  • Extracorporeal Membrane Oxygenation / adverse effects
  • Heart Defects, Congenital / surgery*
  • Humans
  • Infant
  • Infant, Newborn
  • Intensive Care Units
  • Lactic Acid / blood
  • Length of Stay
  • Linear Models
  • Nervous System / growth & development
  • Nervous System / physiopathology*
  • Nervous System Diseases / diagnosis
  • Nervous System Diseases / etiology*
  • Nervous System Diseases / physiopathology
  • Nervous System Diseases / psychology
  • Neuropsychological Tests
  • Psychomotor Performance
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Cardiotonic Agents
  • Lactic Acid